Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population

Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1547-9.

Authors

Sharon A Savage¹, Christian C Abnet, Kashif Haque, Steven D Mark, You-Lin Qiao, Zhi-Wei Dong, Sanford M Dawsey, Philip R Taylor, Stephen J Chanock

Affiliation

¹ Pediatric Oncology Branch, Center for Cancer Research, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. savagesh@mail.nih.gov

PMID: 15342460

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Adenocarcinoma / epidemiology*
Adenocarcinoma / genetics*
Asian People / genetics*
Asian People / statistics & numerical data
Carcinoma, Squamous Cell / epidemiology*
Carcinoma, Squamous Cell / genetics*
Case-Control Studies
China
Cocarcinogenesis
Cohort Studies
Esophageal Neoplasms / epidemiology*
Esophageal Neoplasms / genetics*
Esophageal Neoplasms / immunology
Gene Frequency / genetics
Genetic Variation / genetics
Genetics, Population
Humans
Interleukin-10 / genetics*
Interleukin-2 / genetics*
Interleukin-6 / genetics*
Polymorphism, Genetic / genetics*
Proportional Hazards Models
Stomach Neoplasms / epidemiology*
Stomach Neoplasms / genetics*
Stomach Neoplasms / immunology
Th1 Cells / immunology
Th2 Cells / immunology

Substances

Interleukin-2
Interleukin-6
Interleukin-10